Repro-Med Systems Inc (KRMD, Financial)(30-Year Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2019. Repro-Med Systems Inc designs, manufactures and markets proprietary medical devices for the ambulatory infusion market and emergency medical applications. Repro-Med Systems Inc has a market cap of $385.960 million; its shares were traded at around $9.77 with a P/E ratio of 977.00 and P/S ratio of 16.46. GuruFocus has detected 1 severe warning sign with Repro-Med Systems Inc. .
For the last quarter Repro-Med Systems Inc reported a revenue of $6.22 million, compared with the revenue of $4.27 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $23.2 million, an increase of 33.5% from last year. For the complete 30-year financial data, please go here.. For the last five years Repro-Med Systems Inc had an average revenue growth rate of 19.4% a year.
The reported diluted earnings per share was 1 cents for the year, a decline of 50% from the previous year. The Repro-Med Systems Inc had a decent operating margin of 17.27%, compared with the operating margin of 6.71% a year before. The 10-year historical median operating margin of Repro-Med Systems Inc is 12.64%. The profitability rank of the company is 8 (out of 10).
At the end of the fiscal year, Repro-Med Systems Inc has the cash and cash equivalents of $5.87 million, compared with $3.74 million in the previous year. The long term debt was $0.24 million. Repro-Med Systems Inc has a financial strength rank of 6 (out of 10).
At the current stock price of $9.77, Repro-Med Systems Inc is traded at 1091.5% premium to its historical median P/S valuation band of $0.82. The P/S ratio of the stock is 16.46, while the historical median P/S ratio is 1.36. The stock gained 526.90% during the past 12 months.
For the complete 20-year historical financial data of KRMD, click here.
